Seeing the forest for the trees—single-cell atlases link CD8+ T cells and macrophages to disease progression and treatment response in kidney cancer-Reference-Cited by-同舟云学术

Seeing the forest for the trees—single-cell atlases link CD8+ T cells and macrophages to disease progression and treatment response in kidney cancer

Published:2021-05 Issue:5 Volume:39 Page:594-596
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Koh Mei Yee,Sayegh Nicolas,Agarwal Neeraj

Funder

NCI

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference7 articles.

1. Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma;Bi;Cancer Cell,2021

2. Progressive immune dysfunction with advancing disease stage in renal cell carcinoma;Braun;Cancer Cell,2021

3. An intra-tumoral niche maintains and differentiates stem-like CD8 T cells;Jansen;Nature,2019

4. Single cell sequencing links multiregional immune landscapes and issue resident T cells in ccRCC to tumor topology and therapy efficacy;Krishna;Cancer Cell,2021

5. Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade;Motzer;Cancer Cell,2020

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study;Journal for ImmunoTherapy of Cancer;2024-06

2. A novel risk signature based on liquid-liquid phase separation-related genes reveals prognostic and tumour microenvironmental features in clear cell renal cell carcinoma;Aging;2024-03-27

3. Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma;Scientific Reports;2024-01-17

4. Associations between HIFs and tumor immune checkpoints: mechanism and therapy;Discover Oncology;2024-01-02

5. Deciphering tumor immune microenvironment differences between high-grade serous and endometrioid ovarian cancer to investigate their potential in indicating immunotherapy response;Journal of Ovarian Research;2023-11-22